Catherine J. Wu

Catherine Wu is a leader in developing personalized cancer vaccines targeting patient-specific neoantigens. Her laboratory has pioneered methods for identifying immunogenic neoantigens from tumor sequencing data and designing personalized vaccines that elicit robust anti-tumor T cell responses. Wu's clinical trials have demonstrated the feasibility and efficacy of personalized neoantigen vaccines in melanoma and other cancers.

Catherine Wu是开发靶向患者特异性新抗原的个性化癌症疫苗的领导者。她的实验室开创了从肿瘤测序数据中识别免疫原性新抗原并设计引发强大抗肿瘤T细胞反应的个性化疫苗的方法。Wu的临床试验证明了个性化新抗原疫苗在黑色素瘤和其他癌症中的可行性和有效性。